论文部分内容阅读
目的:探讨中西医结合治疗非静脉曲张上消化道出血患者止血的临床疗效。方法:选择2010年1月到2011年12月期间我院住院的136例非静脉曲张上消化道出血患者,将患者按随机抽样法随机分为两组,67例患者采用常规治疗基础上加用洛赛克针剂治疗作为对照组。69例患者作为研究组,在对照组治疗的基础上加用复方中药治疗,比较两组的止血时间、显效时间、治疗效果、输血量以及不良反应发生率,持续治疗1周。结果:对照组总有效率为77.6%,研究组总有效率为94.2%,与对照组比,差异显著,有统计学意义(P<0.05);与对照组止血时间(14.85±2.56)h、显效时间(9.49±2.64)h、输血量(2.86±1.53)U比较,研究组患者各指标明显改善,有统计学意义(P<0.05);对照组患者不良反应发生率为7.5%,观察组不良反应发生率为5.8%,两组互相比较,差异不显著,没有统计学意义。结论:中西医结合治疗非静脉曲张上消化道出血效果好于单纯西医治疗,疗效显著,不良反应发生率低,值得临床推广。
Objective: To explore the clinical efficacy of integrated traditional Chinese and western medicine in the treatment of patients with non-variceal bleeding in patients with upper gastrointestinal bleeding. Methods: From January 2010 to December 2011 in our hospital 136 cases of non-variceal upper gastrointestinal bleeding patients were randomly divided into two groups according to random sampling method, 67 patients were treated with conventional therapy plus Losec injection as a control group. Sixty-nine patients served as the study group, treated with compound Chinese herbs on the basis of the control group, and compared the bleeding time, the effective time, the therapeutic effect, the blood transfusion and the incidence of adverse reactions in the two groups for 1 week. Results: The total effective rate in the control group was 77.6%, the total effective rate in the study group was 94.2%, which was significantly higher than that in the control group (P <0.05). Compared with the control group, the total effective rate was 14.85 ± 2.56 h, The effective time (9.49 ± 2.64) h, blood transfusion (2.86 ± 1.53) U, the study group significantly improved the indicators, with statistical significance (P <0.05); adverse reactions in the control group was 7.5% The incidence of adverse reactions was 5.8%, the two groups compared with each other, the difference was not significant, not statistically significant. Conclusion: Integrative treatment of non-varices upper gastrointestinal bleeding better than Western medicine alone, with a significant effect, the incidence of adverse reactions is low, worthy of clinical promotion.